NO951241D0 - Forbedret indolbiosyntese - Google Patents

Forbedret indolbiosyntese

Info

Publication number
NO951241D0
NO951241D0 NO951241A NO951241A NO951241D0 NO 951241 D0 NO951241 D0 NO 951241D0 NO 951241 A NO951241 A NO 951241A NO 951241 A NO951241 A NO 951241A NO 951241 D0 NO951241 D0 NO 951241D0
Authority
NO
Norway
Prior art keywords
improved
biosynthesis
indole
indole biosynthesis
improved indole
Prior art date
Application number
NO951241A
Other languages
English (en)
Other versions
NO951241L (no
Inventor
Douglas C Murdock
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/956,697 external-priority patent/US5374543A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO951241D0 publication Critical patent/NO951241D0/no
Publication of NO951241L publication Critical patent/NO951241L/no

Links

NO951241A 1992-10-02 1995-03-30 Forbedret indolbiosyntese NO951241L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/956,697 US5374543A (en) 1992-10-02 1992-10-02 Enhanced indole biosynthesis
PCT/US1993/009433 WO1994008035A1 (en) 1992-10-02 1993-09-30 Enhanced indole biosynthesis

Publications (2)

Publication Number Publication Date
NO951241D0 true NO951241D0 (no) 1995-03-30
NO951241L NO951241L (no) 1995-06-02

Family

ID=26787049

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951241A NO951241L (no) 1992-10-02 1995-03-30 Forbedret indolbiosyntese

Country Status (1)

Country Link
NO (1) NO951241L (no)

Also Published As

Publication number Publication date
NO951241L (no) 1995-06-02

Similar Documents

Publication Publication Date Title
FI944969A (fi) Indolijohdannaisia
NO943913D0 (no) Indol-derivater
DE69522717D1 (de) Chinazolinderivate
DE122009000076I1 (de) Chinazolin-derivate
NO961475L (no) Indol-derivater
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DE69330497T2 (de) Chinazolin-derivate
DE69212058D1 (de) Indol-Derivate
DE59308714D1 (de) Cyclobutan-benzol-derivate
DE69601527T2 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
FI940310A0 (fi) Indoleja
ATE240307T1 (de) Diarylalkenylamin-derivate
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
DK0725061T3 (da) Substituerede indolderivater
ATE225347T1 (de) Aza-anthracyclinone-derivate
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
NO951241D0 (no) Forbedret indolbiosyntese
ATA45796A (de) Lysin-prolin-derivate
NO932638D0 (no) 21-klor-pregnanderivat
DE59605373D1 (de) Substituierte Indol-Derivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application